Trastuzumab Terminated Phase 2 Trials for Neoplasms, Metastasis / Breast Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0049672 (Neoplasms, Metastasis) DBCOND0028036 (Breast Cancer)	Terminated	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00377780	Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer	Docetaxel (DB01248) Doxorubicin (DB00997) Trastuzumab (DB00072)